Moderna, Merck mRNA Therapy Succeeds in Late-Stage Trial, U.S. Healthcare Sector Rallies 4% This Week
Moderna and Merck announced on Wednesday (August 19) that their mRNA therapy successfully halted recurrence or spread of melanoma in over 1,000 patients during late-stage clinical trials, lifting the healthcare sector to its best weekly
MRNA0.73%
GateNews·08-21 19:52
